SCHEMBL29819920

SCHEMBL29819920

CC(=O)N1CCCC[C@@H]1Cn1ncc2cnc(Cl)nc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AURKA O14965 3/20 0.36
▸ CDK1 P06493 3/20 0.36
▸ AURKB Q96GD4 3/20 0.36
▸ PDE8B O95263 1/20 0.36
▸ IRAK4 Q9NWZ3 1/20 0.35
▸ OPRK1 P41145 6/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ NFKB1 P19838 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ OPRD1 P41143 1/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ BLM P54132 1/20 0.34
▸ PMP22 Q01453 1/20 0.34
▸ DRD4 P21917 1/20 0.34
▸ SLC6A3 Q01959 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27156388 1.00 AURKA (0.36) AURKACDK1AURKBPDE8BIRAK4
SCHEMBL27156644 1.00 AURKA (0.36) AURKACDK1AURKBPDE8BIRAK4
SCHEMBL27156392 1.00 AURKA (0.36) AURKACDK1AURKBPDE8BIRAK4
SCHEMBL29819718 1.00 AURKA (0.36) AURKACDK1AURKBPDE8BIRAK4
SCHEMBL27156880 0.97 AURKA (0.37) AURKACDK1AURKBPDE8BIRAK4
SCHEMBL27156527 0.97 AURKA (0.37) AURKACDK1AURKBPDE8BIRAK4
SCHEMBL27156701 0.92 IL1B (0.33) AURKACDK1AURKBMDM4MDM2
SCHEMBL27156706 0.92 IL1B (0.33) AURKACDK1AURKBMDM4MDM2
SCHEMBL29819745 0.92 IL1B (0.33) AURKACDK1AURKBMDM4MDM2
SCHEMBL27156738 0.90 AURKA (0.35) AURKACDK1AURKBPDE8BOPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022197641-A1 1H-PYRAZOLO[3,4-D]PYRIMIDIN-6-YL-AMINE DERIVATIVES AS HEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) MODULATORS AND/OR INHIBITORS FOR THE TREATMENT OF CANCER AND OTHER DISEASES RAPT THERAPEUTICS, INC. (US) 2022-09-22 — — WO disclosed
Send feedback